Compare · BTI vs BTMD
BTI vs BTMD
Side-by-side comparison of British American Tobacco Industries p.l.c. (BTI) and Biote Corp. (BTMD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BTI and BTMD operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- BTI is the larger of the two at $135.97B, about 1470.8x BTMD ($92.5M).
- Over the past year, BTI is up 24.6% and BTMD is down 42.9% - BTI leads by 67.5 points.
- BTI has been more active in the news (8 items in the past 4 weeks vs 5 for BTMD).
- BTI has more recent analyst coverage (14 ratings vs 4 for BTMD).
PerformanceBTI+24.57%BTMD-42.89%
2025-06-16+0.00%2026-06-15
- Company
- British American Tobacco Industries p.l.c.
- Biote Corp.
- Price
- $61.05-2.09%
- $2.25-8.16%
- Market cap
- $135.97B
- $92.5M
- 1M return
- -8.47%
- +16.28%
- 1Y return
- +24.57%
- -42.89%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NYSE
- NASDAQ
- IPO
- 1998
- News (4w)
- 8
- 5
- Recent ratings
- 14
- 4
BTI
British American Tobacco Industries p.l.c.
British American Tobacco p.l.c. provides tobacco and nicotine products to consumers worldwide. It offers vapour products, tobacco heating products, and modern oral products; combustible products; and traditional oral products, such as Swedish-style snus and American moist snuff. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.
Latest BTI
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
- Large owner Bt De Investments Inc. converted options into 95,281,277 shares and was granted 14,662,765 shares (SEC Form 4)
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
Latest BTMD
- SEC Form 4 filed by Director Christensen Bret
- SEC Form 4 filed by Executive Chairman Beer Marc D
- Biote Corp. filed SEC Form 8-K: Leadership Update
- Biote Appoints Komal Bajaj, MD, MS as Chief Medical Officer
- Biote Names Bob Peterson, Current Chief Financial and Chief Business Officer, as Interim CEO
- SEC Form 8-K filed by Biote Corp.
- SEC Form 4 filed by Director Heyer Andrew R
- Director Morris Debra L converted options into 21,407 shares, increasing direct ownership by 43% to 71,562 units (SEC Form 4)
- SEC Form 4 filed by Director Cone Stephen Mark
- SEC Form 4 filed by Director Jacoby Dana Lynn